Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Want to cut your energy bills? Here’s how five experts are doing it 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
ALLEN, Texas, Feb. 23, 2017 -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.05 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2017 to stockholders of record at the close of business on March 15, 2017.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
